What you need to know…
-
Effects of HIV on heart and vasculature
-
Assessment of CAD in this population
-
Utility of risk prediction models
Supporting Materials
Executive Summary | Editorial |Top 10 Things to Know | News Release
Working Group Topics
- Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors
- Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy
- Effects of HIV infection and antiretroviral therapy on the heart and vasculature
- Screening and assessment of coronary heart disease in HIV-infected patients.
- Development of appropriate coronary heart disease risk prediction models in HIV-infected patients
- Prevention strategies for cardiovascular disease in HIV-infected patients
